Literature DB >> 25957880

Axial spondyloarthritis: the heart of the matter.

Lianne S Gensler1.   

Abstract

A variety of cardiovascular clinical manifestations have been described in patients with spondyloarthritis, especially in well-established ankylosing spondylitis. These include both structural heart disease, conduction defects and ischemic heart disease. The true prevalence of cardiovascular involvement in patients with axial spondyloarthritis, including non-radiographic disease needs to be further defined.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25957880     DOI： 10.1007/s10067-015-2959-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  33 in total

Review 1.  Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis.

Authors:  Sylvain Mathieu; Laure Gossec; Maxime Dougados; Martin Soubrier
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

2.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

3.  Heart conduction disturbance: an HLA-B27 associated disease.

Authors:  A J Peeters; S ten Wolde; M I Sedney; R R de Vries; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

4.  Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis.

Authors:  Ann Bremander; Ingemar F Petersson; Stefan Bergman; Martin Englund
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

Review 5.  Diastolic left ventricular dysfunction in ankylosing spondylitis--a systematic review and meta-analysis.

Authors:  Sjoerd C Heslinga; Carlo J Van Dongen; Thelma C Konings; Mike J Peters; Irene E Van der Horst-Bruinsma; Yvo M Smulders; Michael T Nurmohamed
Journal:  Semin Arthritis Rheum       Date:  2014-02-14       Impact factor: 5.532

6.  Complete heart block--another HLA B27 associated disease manifestation.

Authors:  L Bergfeldt; E Möller
Journal:  Tissue Antigens       Date:  1983-05

Review 7.  Cardiovascular morbidity and mortality in rheumatoid arthritis.

Authors:  Sherine E Gabriel
Journal:  Am J Med       Date:  2008-10       Impact factor: 4.965

8.  Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease.

Authors:  Anne Grete Semb; Tore K Kvien; David A DeMicco; Rana Fayyad; Chuan-Chuan Wun; John C LaRosa; John Betteridge; Terje R Pedersen; Ingar Holme
Journal:  Arthritis Rheum       Date:  2012-09

9.  Increased risk of ischemic stroke in young patients with ankylosing spondylitis: a population-based longitudinal follow-up study.

Authors:  Chia-Wei Lin; Ya-Ping Huang; Yueh-Hsia Chiu; Yu-Tsun Ho; Shin-Liang Pan
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

10.  Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis--a population-based longitudinal follow-up study.

Authors:  Ya-Ping Huang; Yen-Ho Wang; Shin-Liang Pan
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240
View more
  6 in total

Review 1.  Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.

Authors:  Santos Castañeda; Carlos González-Juanatey; Miguel A González-Gay
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

2.  Mesenchymal TNFR2 promotes the development of polyarthritis and comorbid heart valve stenosis.

Authors:  Maria Sakkou; Panagiotis Chouvardas; Lydia Ntari; Alejandro Prados; Kristin Moreth; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabe de Angelis; Maria C Denis; Niki Karagianni; George Kollias
Journal:  JCI Insight       Date:  2018-04-05

3.  Cardiovascular events prediction by left ventricular longitudinal strain and serum high-sensitivity troponin I in patients with axial spondyloarthritis.

Authors:  Yan Chen; Yap-Hang Chan; Ho-Yin Chung; Mei-Zhen Wu; Yu-Juan Yu; Kang-Li Pi; Chak-Sing Lau; Hung-Fat Tse; Kai-Hang Yiu
Journal:  Clin Rheumatol       Date:  2020-05-13       Impact factor: 2.980

4.  Increased risks of aortic regurgitation and atrial fibrillation in radiographic axial spondyloarthritis patients: a 10-year nationwide cohort study.

Authors:  Hong Ki Min; Hae-Rim Kim; Sang-Heon Lee; Sojeong Park; Minae Park; Yeon Sik Hong; Moon-Young Kim; Sung-Hwan Park; Kwi Young Kang
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-03-30       Impact factor: 5.346

5.  Prevalence and Risk for Bundle Branch Block, Atrioventricular Block and Pacemaker Implantation in Spondyloarthritis. A Systematic Review of the Literature.

Authors:  Hye Sang Park; Ana Laiz; Petra Díaz Del Campo; María A Martín Martínez; M Guerra-Rodriguez; Concepcion Alonso-Martin; Jesus Sanchez-Vega; Hector Corominas
Journal:  Front Med (Lausanne)       Date:  2022-03-25

6.  Heart Involvement in a Moroccan Population with Spondyloarthritis: A Cross-sectional Study.

Authors:  Jalila Eddarami; Hamida Azzouzi; Linda Ichchou
Journal:  J Saudi Heart Assoc       Date:  2021-07-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.